Location History:
- Madison, CT (US) (2002)
- Zionsville, IN (US) (2002 - 2012)
- Westfield, IN (US) (2010 - 2012)
Company Filing History:
20 out of 4,447 
8 out of 3,685 
1 out of 4,770 
Years Active: 2002-2012
Title: The Innovations of Owen Brendan Wallace: A Pioneer in Pharmaceutical Patents
Introduction
Owen Brendan Wallace, based in Zionsville, Indiana, is a distinguished inventor with a remarkable portfolio of 28 patents. His inventive contributions primarily focus on innovative pharmaceutical solutions addressing significant health concerns, reflecting a commitment to advancing medical science.
Latest Patents
Among his latest patents, Wallace has developed selective estrogen receptor modulators aimed at the treatment of vasomotor symptoms. This invention, characterized by a specific chemical formula, is particularly beneficial for alleviating symptoms such as hot flashes and night sweats experienced by women during menopause.
In addition, Wallace’s ingenuity has led to the creation of novel inhibitors of 11-beta-hydroxysteroid dehydrogenase 1, which showcase promising potential in tackling various health conditions, including diabetes and metabolic syndrome. This highlights not only the versatility of his innovations but also their importance in modern therapeutics, given the increasing prevalence of these ailments.
Career Highlights
Throughout his career, Owen Brendan Wallace has made significant strides in the pharmaceutical industry by working with reputable companies such as Eli Lilly and Company and Bristol-Myers Squibb Company. His tenure at these organizations has allowed him to apply his innovative prowess in real-world applications, enhancing the efficacy of treatments available to patients.
Collaborations
Collaboration has been a crucial element of Wallace's success. Notable coworkers include Yanping Xu and Tao Wang, with whom he has worked closely to propel research and development in their respective fields. These partnerships have not only fostered innovative ideas but have also contributed to the successful realization of breakthrough health solutions.
Conclusion
Owen Brendan Wallace’s journey as an inventor exemplifies the impact that targeted innovations can have on improving health outcomes. His portfolio, characterized by a focus on significant health-related concerns, underscores the essential role that inventors play in advancing medical science and enhancing the quality of life for individuals worldwide. With a determined spirit and collaborative approach, Wallace continues to inspire and lead in the realm of pharmaceutical innovations.